Millions of people suffer from a herpes virus infection. Millions more suffer from HPV. Treatments are limited. There are no drugs against HPV, and the drugs against the herpes virus have limited effectiveness.
A recent post-marketing clinical study, published in the Pharmacology & Pharmacy in September 2013 by Scientific Research Publishing, offers hope to the millions infected with these viruses. The study showed that Gene-Eden-VIR, a natural product, safely and effectively reduced symptoms of herpes and HPV infections.The study was conducted by Hanan Polansky and Edan Itzkovitz from the Center for the Biology of Chronic Disease (CBCD).
The researchers gave Gene-Eden-VIR to individuals infected with one or more of the following viruses: Herpes Simplex Virus 1 (HSV-1), Herpes Simplex Virus 2 (HSV-2), Human Papillomavirus (HPV), Hepatitis C Virus (HCV), Epstein Barr Virus (EBV), and Human Cytomegalovirus (CMV). As a result, the participants reported a significant reduction in the severity, duration and frequency of their symptoms.
Gene-Eden-VIR was developed through a unique process. Scientists at polyDNA used a psycho-linguistic computer program called Computer Intuition to analyze thousands of scientific papers. Using the program, the scientists predicted that Gene-Eden-VIR would be antiviral. The clinical study confirmed their prediction. As the authors of the clinical study wrote: Gene-Eden-VIR “safely and effectively decreases symptoms in individuals infected with the HPV, HSV, EBV, HCMV, and HCV” viruses.
Based on these results, study authors concluded that healthcare practitioners should recommend Gene-Eden-VIR as a safe and effective antiviral treatment to the millions of people infected with these viruses.
2,316 total views, 6 views today